MAOB and Parkinson disease: Rasagiline is a selective, irreversible MAO-B inhibitor with a therapeutic indication in PD patients either as monotherapy or in combination with LD [48,49,50,51], with a demonstrated significant efficacy in reducing motor fluctuations.